Cross-Sectional Evaluation of the Mean Heart Doses in Breast Cancer Patients Treated with Three-Dimensional Conformal Radiotherapy at INMOL Cancer Hospital, Lahore
Research Article
DOI:
https://doi.org/10.31580/2f85fd20Keywords:
3D-CRT, Breast cancer, Radiotherapy planningAbstract
This study aims to determine mean heart doses (MHD) received by breast cancer patients who underwent 3D-CRT treatment at INMOL Cancer Hospital in Lahore. The six-month cross-sectional research took place at INMOL Cancer Hospital, Lahore according to Letter No. INMOL-128, 15-06-2024. The research studied 126 female breast cancer patients who received 3D-CRT treatment at INMOL Cancer Hospital with non-probability purposive sampling. The research team obtained patient data points focused on age alongside surgical procedures along with affected sites from breast cancer patients. The research utilized computed tomography (CT) plans to calculate mean heart doses and carried out statistical evaluations with version 21 of SPSS. The patients had an average age of 43.31 ± 9.29 years. The heart received an average 2.429 ± 2.367 Gy of radiation dose throughout all cases. The patients with left-sided breast tumors received considerably higher mean heart doses amounting to 4.722 ± 0.753 Gy than those with right-sided breast cancers who received 0.136 ± 0.198 Gy with p-value < 0.001. Among patients who received left-sided modified radical mastectomy (LT-MRM) treatment the mean heart dose reached its peak value of 5.207 + 0.547 Gy whereas right-sided breast-conserving surgery (RT-BCS) produced the least amount of heart dose at 0.105 + 0.148 Gy. ANOVA tests showed that surgical methods produce distinct mean heart doses that reach statistical significance (p < 0.001). The mean heart doses between age groups showed no statistical differences based on p = 0.371. Mean heart doses show a major difference between patients diagnosed with left-sided versus right-sided breast cancer when receiving 3D-CRT care since left-sided patients face significantly higher cardiac exposure risks. Radiotherapy planning requires customization to lower the cardiac health risks for patients diagnosed with left-sided breast cancer based on study findings.
References
Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 2021;134(7):783-791.
Abdul Rehman M, Tahir E, Ghulam Hussain H, Khalid A, Taqi SM, Meenai EA. Awareness regarding breast cancer amongst women in Pakistan: A systematic review and meta-analysis. PLoS One. 2024;19(3):e0298275.
Zhu JW, Charkhchi P, Adekunte S, Akbari MR. What is Known about Breast Cancer in Young Women? Cancers (Basel). 2023;15(6):1917.
Jain U, Jain B, Fayanju OM, Chino F, Dee EC. Disparities in timely treatment among young women with breast cancer. Am J Surg. 2022;224(2):811-815.
Meattini I, Becherini C, Caini S, Coles CE, Cortes J, Curigliano G, de Azambuja E, Isacke CM, Harbeck N, Kaidar-Person O, Marangoni E, Offersen BV, Rugo HS, Salvestrini V, Visani L, Morandi A, Lambertini M, Poortmans P, Livi L; Consensus Panellist Group. International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations. Lancet Oncol. 2024;25(2):e73-e83.
Hennequin C, Belkacémi Y, Bourgier C, Cowen D, Cutuli B, Fourquet A, Hannoun-Lévi JM, Pasquier D, Racadot S, Rivera S. Radiotherapy of breast cancer. Cancer Radiother. 2022;26(1-2):221-230.
Quintero-Martinez JA, Cordova-Madera SN, Villarraga HR. Radiation-Induced Heart Disease. J Clin Med. 2021;11(1):146.
Naimi Z, Moujahed R, Neji H, Yahyaoui J, Hamdoun A, Bohli M, Kochbati L. Cardiac substructures exposure in left-sided breast cancer radiotherapy: Is the mean heart dose a reliable predictor of cardiac toxicity? Cancer Radiother. 2021;25(3):229-236.
Wang SY, Tsai WT, Lin KH, Yu CW, Yang SY, Shueng PW, Wu YW, Hsu CX, Wu TH. Integrating subvolume dose and myocardial perfusion imaging parameters to assess the impact of radiation therapy on heart function in breast cancer patients: A comparative analysis between left- and right-sided breast cancer. Thorac Cancer. 2023;14(26):2696-2706.
Diremsizoglu U, Topal N, Konuk AO, Suyusal IH, Genc D, Ari O, Cevik HF, Kefeli AU, Aksu MG, Sarper EB. Strategies to Reduce Left Anterior Descending Artery and Left Ventricle Organ Doses in Radiotherapy Planning for Left-Sided Breast Cancer. Rev Cardiovasc Med. 2025;26(2):26366.
Chung SY, Oh J, Chang JS, Shin J, Kim KH, Chun KH, Keum KC, Suh CO, Kang SM, Kim YB. Risk of Cardiac Disease in Patients With Breast Cancer: Impact of Patient-Specific Factors and Individual Heart Dose From Three-Dimensional Radiation Therapy Planning. Int J Radiat Oncol Biol Phys. 2021;110(2):473-481.
Ward R, West K, Latty D, Beldham-Collins R, Jia D, Wang W, Cross S, Gebski V, Ahern V, Stuart K. Patient-Specific Heart Constraint: A Tool for Optimization and Evaluation of Mean Heart Dose in Breast Cancer Patients. Pract Radiat Oncol. 2021;11(2):e154-e162.
Yit LFN, Ng CT, Wong FY, Master Z, Zhou S, Ng WL. Modern-era radiotherapy and ischaemic heart disease-related mortality outcomes in Asian breast-cancer patients. Contemp Oncol (Pozn). 2022;26(1):59-68.
Bogers SLC, Petoukhova AL, Penninkhof JJ, Mast ME, Poortmans PM, Hoogeman MS, Struikmans H. Target Volume Coverage and Organ at Risk Doses for Left-sided Whole-breast Irradiation With or Without Internal Mammary Chain Irradiation: A Comparison Between Three Techniques Representing the Past and the Present. Clin Oncol (R Coll Radiol). 2022;34(8):537-544.
Garg A, Kumar P. Dosimetric Comparison of the Heart and Left Anterior Descending Artery in Patients With Left Breast Cancer Treated With Three-Dimensional Conformal and Intensity-Modulated Radiotherapy. Cureus. 2022;14(1):e21108.
Loap P, Kirova Y. Evaluating cardiac substructure radiation exposure in breast rotational intensity modulated radiation therapy: Effects of cancer laterality, fractionation and deep inspiration breath-hold. Cancer Radiother. 2021;25(1):13-20.
Wang SY, Lin KH, Wu YW, Yu CW, Yang SY, Shueng PW, Hsu CX, Wu TH. Evaluation of the cardiac subvolume dose and myocardial perfusion in left breast cancer patients with postoperative radiotherapy: a prospective study. Scientific reports. 2023;13(1):10578.
Xie H, Tan T, Zhang H, Li Q. Dose prediction for cervical cancer in radiotherapy based on the beam channel generative adversarial network. Heliyon. 2024 ;10(18):e37472.
Clasen SC, Shou H, Freedman G, Plastaras JP, Taunk NK, Kevin Teo BK, Smith AM, Demissei BG, Ky B. Early Cardiac Effects of Contemporary Radiation Therapy in Patients With Breast Cancer. Int J Radiat Oncol Biol Phys. 2021;109(5):1301-1310.
Gocer GPS, Ozer EE. Effect of radiotherapy on coronary arteries and heart in breast-conserving surgery: a dosimetric analysis. Radiol Oncol. 2020;54(1):128-134.
Xu L, Wang H, Wang J, Ren Y, Zhang L, Deng W, Li X. Pre-treatment predictors of cardiac dose exposure in left-sided breast cancer radiotherapy patients after breast conserving surgery. Oncologie. 2023;25(5):461-468.
Nielsen AWM, Thorsen LBJ, Özcan D, Matthiessen LW, Maae E, Milo MLH, Nielsen MH, Tramm T, Overgaard J, Offersen BV; DBCG RT Committee. Internal mammary node irradiation in 4541 node-positive breast cancer patients treated with newer systemic therapies and 3D-based radiotherapy (DBCG IMN2): a prospective, nationwide, population-based cohort study. Lancet Reg Health Eur. 2024;49:101160.
Loving BA, Almahariq MF, Sivapalan S, Levitin R, Qu L, Ramanathan S, Ijaz Z, Dilworth JT. Newly Diagnosed Mental Health Disorders in Patients With Breast Cancer Receiving Radiation Therapy. Int J Radiat Oncol Biol Phys. 2024;120(2):508-515.
Gocer GPS, Ozer EE. Effect of radiotherapy on coronary arteries and heart in breast-conserving surgery: a dosimetric analysis. Radiol Oncol. 2020;54(1):128-134.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Pak-Euro Journal of Medical and Life Sciences

This work is licensed under a Creative Commons Attribution 4.0 International License.